News Releases

Apr 26, 2021
Biodesix to Report First Quarter 2021 Financial Results on May 11, 2021
BOULDER, Colo. --(BUSINESS WIRE)--Apr. 26, 2021-- Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced that it will release financial results for the first quarter ended March 31, 2021 after the close of trading on Tuesday,
Mar 23, 2021
Biodesix Announces Closing of New $30 Million Term Loan
Increases Company’s Net Liquidity Position and Reduces Near-Term Cash Interest Costs BOULDER, Colo. --(BUSINESS WIRE)--Mar. 23, 2021-- Biodesix, Inc. (NASDAQ: BDSX; “Biodesix” or the “Company”) a leading data-driven diagnostic solutions company with a focus in lung disease, announced today that it
Mar 16, 2021
Biodesix Announces Fourth Quarter and Full Year 2020 Results
Full Year 2020 Revenue Growth of 86% on Record Revenue of approximately $46 million BOULDER, Colo. --(BUSINESS WIRE)--Mar. 16, 2021-- Biodesix, Inc. (NASDAQ: BDSX) a leading data-driven diagnostic solutions company with a focus in lung disease, today announced financial and operating results for
Feb 25, 2021
Biodesix CEO Scott Hutton Selected as One of Top 25 Biotech CEOs of 2021
BOULDER, Colo. --(BUSINESS WIRE)--Feb. 25, 2021-- Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced that The Healthcare Technology Report announced Chief Executive Officer, Scott Hutton , as one of the Top 25 Biotech CEOs
Displaying 1 - 10 of 19